FHC
PJP icon

First Heartland Consultants’s Invesco Pharmaceuticals ETF PJP Stock Holding History

First Heartland Consultants’s Portfolio PJP Stock Details PJP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2013
Q3 		– Sell
-915
Closed -$39K – 327
2013
Q2 		$39K Buy
+915
New +$38.1K 0.02% 279

Other funds holding PJP

Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
LPL Financial
LPL Financial San Diego, California $445B AUM 25.58% 1-Year Est. Return
NCM
Niemann Capital Management Stateline, Nevada $788K AUM 23.27% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return
U
UBS Zurich, Switzerland $136B AUM 16.36% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return
PFG
Pacific Financial Group Bellevue, Washington $209M AUM 22.2% 1-Year Est. Return
Bank of Montreal
Bank of Montreal Toronto, Ontario, Canada $304B AUM 35.64% 1-Year Est. Return
RJA
Raymond James & Associates St Petersburg, Florida $164B AUM 33.91% 1-Year Est. Return

First Heartland Consultants's PJP Position: Q3 2013 in Review

First Heartland Consultants sold out of Invesco Pharmaceuticals ETF (PJP) in Q3 2013, closing a stake of 915 shares — an estimated $39K sold.

First Heartland Consultants first reported a position in PJP in Q2 2013 and held it in 1 quarter. The position peaked at $39K in Q2 2013. 69 funds tracked by Wall St. Rank hold PJP as of Q3 2013.

  • First Heartland Consultants reported no remaining Invesco Pharmaceuticals ETF position as of Q3 2013 after selling out during the quarter.
  • First Heartland Consultants sold 915 Invesco Pharmaceuticals ETF shares in Q3 2013, an estimated $39K.
  • First Heartland Consultants first reported a position in Invesco Pharmaceuticals ETF in Q2 2013 and held it in 1 quarter.
  • First Heartland Consultants's Invesco Pharmaceuticals ETF position peaked at $39K in Q2 2013.
  • 69 funds tracked by Wall St. Rank held Invesco Pharmaceuticals ETF as of Q3 2013.

Based on First Heartland Consultants's 13F filing for Q3 2013, filed 14 Nov 2013.